SPADEL SA (SPA.BR) Stock Fundamental Analysis
Europe - EBR:SPA - BE0003798155 - Common Stock
228 EUR
+4 (+1.79%)
Taking everything into account, SPA scores 5 out of 10 in our fundamental rating. SPA was compared to 24 industry peers in the Beverages industry. SPA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. SPA is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year SPA was profitable.
In the past year SPA had a positive cash flow from operations.
In the past 5 years SPA has always been profitable.
Each year in the past 5 years SPA had a positive operating cash flow.
1.2 Ratios
SPA's Return On Assets of 8.71% is amongst the best of the industry. SPA outperforms 91.67% of its industry peers.
SPA has a Return On Equity of 13.22%. This is in the better half of the industry: SPA outperforms 75.00% of its industry peers.
SPA's Return On Invested Capital of 11.50% is amongst the best of the industry. SPA outperforms 83.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SPA is in line with the industry average of 7.87%.
The last Return On Invested Capital (11.50%) for SPA is above the 3 year average (8.57%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.71% | ||
| ROE | 13.22% | ||
| ROIC | 11.5% |
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
1.3 Margins
The Profit Margin of SPA (10.82%) is better than 70.83% of its industry peers.
In the last couple of years the Profit Margin of SPA has grown nicely.
SPA has a Operating Margin (12.85%) which is in line with its industry peers.
In the last couple of years the Operating Margin of SPA has grown nicely.
SPA has a Gross Margin of 39.41%. This is in the lower half of the industry: SPA underperforms 62.50% of its industry peers.
In the last couple of years the Gross Margin of SPA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.85% | ||
| PM (TTM) | 10.82% | ||
| GM | 39.41% |
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SPA is creating some value.
Compared to 1 year ago, SPA has about the same amount of shares outstanding.
SPA has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPA has a worse debt to assets ratio.
2.2 Solvency
SPA has an Altman-Z score of 5.80. This indicates that SPA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.80, SPA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of SPA is 0.12, which is an excellent value as it means it would take SPA, only 0.12 years of fcf income to pay off all of its debts.
SPA's Debt to FCF ratio of 0.12 is amongst the best of the industry. SPA outperforms 100.00% of its industry peers.
SPA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
SPA's Debt to Equity ratio of 0.01 is amongst the best of the industry. SPA outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.12 | ||
| Altman-Z | 5.8 |
ROIC/WACC1.46
WACC7.87%
2.3 Liquidity
SPA has a Current Ratio of 1.82. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
SPA has a Current ratio of 1.82. This is in the better half of the industry: SPA outperforms 66.67% of its industry peers.
SPA has a Quick Ratio of 1.63. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.63, SPA belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 45.32% over the past year.
The Earnings Per Share has been growing by 8.75% on average over the past years. This is quite good.
Looking at the last year, SPA shows a quite strong growth in Revenue. The Revenue has grown by 9.66% in the last year.
The Revenue has been growing slightly by 4.92% on average over the past years.
EPS 1Y (TTM)45.32%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%64.21%
Revenue 1Y (TTM)9.66%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%12.07%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
SPA is valuated rather expensively with a Price/Earnings ratio of 23.05.
SPA's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, SPA is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.05 | ||
| Fwd PE | N/A |
4.2 Price Multiples
SPA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, SPA is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.01 | ||
| EV/EBITDA | 11.06 |
4.3 Compensation for Growth
The decent profitability rating of SPA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.63
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 1.00%, SPA is not a good candidate for dividend investing.
With a Dividend Yield of 1.00, SPA pays less dividend than the industry average, which is at 2.88. 87.50% of the companies listed in the same industry pay a better dividend than SPA!
With a Dividend Yield of 1.00, SPA pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1% |
5.2 History
The dividend of SPA has a limited annual growth rate of 1.92%.
Dividend Growth(5Y)1.92%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
22.25% of the earnings are spent on dividend by SPA. This is a low number and sustainable payout ratio.
The dividend of SPA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.25%
EPS Next 2YN/A
EPS Next 3YN/A
EBR:SPA (9/12/2025, 7:00:00 PM)
228
+4 (+1.79%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners97.59%
Ins Owner ChangeN/A
Market Cap946.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1% |
Yearly Dividend2.2
Dividend Growth(5Y)1.92%
DP22.25%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.05 | ||
| Fwd PE | N/A | ||
| P/S | 2.49 | ||
| P/FCF | 21.01 | ||
| P/OCF | 13.81 | ||
| P/B | 3.05 | ||
| P/tB | 4.76 | ||
| EV/EBITDA | 11.06 |
EPS(TTM)9.89
EY4.34%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)10.85
FCFY4.76%
OCF(TTM)16.51
OCFY7.24%
SpS91.41
BVpS74.79
TBVpS47.88
PEG (NY)N/A
PEG (5Y)2.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.71% | ||
| ROE | 13.22% | ||
| ROCE | 14.26% | ||
| ROIC | 11.5% | ||
| ROICexc | 20.47% | ||
| ROICexgc | 48.93% | ||
| OM | 12.85% | ||
| PM (TTM) | 10.82% | ||
| GM | 39.41% | ||
| FCFM | 11.87% |
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
ROICexc(3y)13.94%
ROICexc(5y)13.81%
ROICexgc(3y)32.94%
ROICexgc(5y)32.52%
ROCE(3y)10.63%
ROCE(5y)11.39%
ROICexcg growth 3Y14.92%
ROICexcg growth 5Y8.53%
ROICexc growth 3Y13.66%
ROICexc growth 5Y8.37%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
F-Score6
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.12 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 105.67% | ||
| Cap/Sales | 6.19% | ||
| Interest Coverage | 66.51 | ||
| Cash Conversion | 96.54% | ||
| Profit Quality | 109.76% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 5.8 |
F-Score6
WACC7.87%
ROIC/WACC1.46
Cap/Depr(3y)93.53%
Cap/Depr(5y)93.22%
Cap/Sales(3y)5.83%
Cap/Sales(5y)6.29%
Profit Quality(3y)136.29%
Profit Quality(5y)124.06%
High Growth Momentum
Growth
EPS 1Y (TTM)45.32%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%64.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.66%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%12.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.35%
EBIT growth 3Y9.82%
EBIT growth 5Y6.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.06%
FCF growth 3Y16.51%
FCF growth 5Y18.57%
OCF growth 1Y10.87%
OCF growth 3Y13.89%
OCF growth 5Y11.4%